## Bio

I am an Oxford CSC-NDM Prize student with [Christopher Yau](http://cwcyau.github.io)  
and [Ahmed Ahmed](https://www.wrh.ox.ac.uk/team/ahmed-ahmed) at the [Wellcome Centre for Human Genetics (WHG)](http://www.well.ox.ac.uk/home) 
and at the [MRC Weatherall Institute of Molecular Medicine (WIMM)](https://www.imm.ox.ac.uk/) at the [University of Oxford](http://www.ox.ac.uk/).

I am working on single-cell methods for understanding ovarian cancer.



## Publications


**Z. Hu**, A. Alsaadi, N. Wietek, L. Santana González, C. Yau, A. A. Ahmed. Abstrast: Deep single-cell RNA-seq of the putative cell of origin revealed a novel molecular subtype of high-grade serous ovarian cancer with poor prognosis. *Cancer Research* 79 (13 Supplement), 467-467. DOI: [10.1158/1538-7445.SABCS18-467](http://cancerres.aacrjournals.org/content/79/13_Supplement/467.short)


M. P. Menden, D. Wang, M. J. Mason, B. Szalai, K. C. Bulusu, Y. Guan, T. Yu, J. Kang, M. Jeon, R.Wolfinger, T. Nguyen, M. Zaslavskiy, **AstraZeneca-Sanger Drug Combination DREAM Consortium**, I. Sock Jang, Z. Ghazoui, M. Eren Ahsen, R. Vogel, E. Chaibub Neto, T. Norman, E. K. Y. Tang, M.J. Garnett, G. Y. Di Veroli, S. Fawell, G. Stolovitzky, J. Guinney*, J. R. Dry*   J. Saez-Rodriguez*. Community assessment to advance computational prediction of cancer drug combinations in a phar-macogenomic screen. *Nature Communications* 10, 2674 (2019). https://www.nature.com/articles/s41467-019-09799-2


T. Motohara, K. Masuda, M. Morotti, Y. Zheng, S. El-Sahhar, K. Chong, N. Wietek, A. Alsaadi, M.Karaminejadranjbar, **Z. Hu**, M. Artibani, L. Santana Gonzalez, H. Katabuchi, H. Saya and A. A. Ahmed. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestrationof the adipose-rich metastatic microenvironment. *Oncogene* 38, 2885−2898 (2019). DOI: [https://doi.org/10.1038/s41388-018-0637-x](https://www.nature.com/articles/s41388-018-0637-x)


**Z. Hu**, C. Yau & A. A. Ahmed. A pan-cancer genome-wide analysis reveals tumour dependencies by induction of nonsense-mediated decay. *Nat Commun* 8, 15943 (2017). [doi:10.1038/ncomms15943](https://www.nature.com/articles/ncomms15943)


## Preprint


**Z. Hu**, M. Artibani, A. Alsaadi, N. Wietek, M. Morotti, L. Santana Gonzalez, S. El-Sahhar, M. KaramiNejadRanjbar, G. Mallett, T. Shi, K. Masuda, Y. Zheng, K. Chong, S. Damato, S. Dhar, R. Garruto Campanile, H. Soleymani majd, V. Cerundolo, T. Sauka-Spengler,  C. Yau*, A. A. Ahmed*. The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells. *BioRxiv*. January 2019: 672626. http://biorxiv.org/content/early/2019/06/17/672626


## R package

Masonmd: making sense of nonsense-mediated decay. ([Link](https://github.com/zhiyhu/masonmd))
